These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis. Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881 [TBL] [Abstract][Full Text] [Related]
27. Amyloid Neuropathy: From Pathophysiology to Treatment in Light-Chain Amyloidosis and Hereditary Transthyretin Amyloidosis. Chompoopong P; Mauermann ML; Siddiqi H; Peltier A Ann Neurol; 2024 Sep; 96(3):423-440. PubMed ID: 38923548 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area. Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417 [TBL] [Abstract][Full Text] [Related]
29. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273 [TBL] [Abstract][Full Text] [Related]
30. Recent progress in the understanding and treatment of transthyretin amyloidosis. Sekijima Y J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898 [TBL] [Abstract][Full Text] [Related]
31. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Rudolph T; Kurz MW; Farbu E Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975 [TBL] [Abstract][Full Text] [Related]
32. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy. Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783 [TBL] [Abstract][Full Text] [Related]
33. Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review. Lee YJ; Oh J; Hwang SK; Lee EJ; Yang DH; Kim YJ; Kwon S; Hyun MC Neuropediatrics; 2019 Oct; 50(5):322-326. PubMed ID: 31319424 [TBL] [Abstract][Full Text] [Related]
34. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation. Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035 [TBL] [Abstract][Full Text] [Related]
35. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455 [TBL] [Abstract][Full Text] [Related]
36. A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred. Jimenez-Zepeda VH; Bahlis NJ; Gilbertson J; Rendell N; Porcari R; Lachmann HJ; Gillmore JD; Hawkins PN; Rowczenio DM Amyloid; 2015 Mar; 22(1):26-30. PubMed ID: 25430583 [TBL] [Abstract][Full Text] [Related]
37. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Sekijima Y; Hammarström P; Matsumura M; Shimizu Y; Iwata M; Tokuda T; Ikeda S; Kelly JW Lab Invest; 2003 Mar; 83(3):409-17. PubMed ID: 12649341 [TBL] [Abstract][Full Text] [Related]